Tocilizumab and COVID-19: Timing of Administration Assessment - Sorbonne Université
Journal Articles Infectious Diseases Now Year : 2022

Tocilizumab and COVID-19: Timing of Administration Assessment

Fichier principal
Vignette du fichier
S2666991921004206.pdf (291.2 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03707363 , version 1 (22-07-2024)

Licence

Identifiers

Cite

Q. Richier, V. Jachiet, V. Bonnemains, L. Plaçais, N. Abisror, et al.. Tocilizumab and COVID-19: Timing of Administration Assessment. Infectious Diseases Now, 2022, 52 (1), pp.31--34. ⟨10.1016/j.idnow.2021.06.304⟩. ⟨hal-03707363⟩
50 View
2 Download

Altmetric

Share

More